Camp4 Therapeutics (CAMP) Cash from Operations (2023 - 2026)
Camp4 Therapeutics (CAMP) posted Cash from Operations of 10981000.0 for Q1 2026, down 275.78% sequentially from 6247000.0 in Q4 2025, and up 23.13% YoY from 8917887.9 in Q1 2025.
Camp4 Therapeutics (CAMP) Cash from Operations (2023 - 2026) Analysis & Trends
Camp4 Therapeutics has reported Cash from Operations for 4 years, with the latest figure at 10981000.0 in Q1 2026.
- Quarterly Cash from Operations rose 23.13% year-over-year to 10981000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 26248000.0 (up 46.11% YoY) and the FY2025 annual result came in at 29553000.0, up 35.14% from the prior year.
- Cash from Operations fell to 10981000.0 in Q1 2026 per CAMP's latest filing, from 6247000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 6247000.0 in Q4 2025 and troughed at 14286000.0 in Q1 2025.
- A 4-year average of 9787900.0 and a median of 11157000.0 in 2024 frame the typical range for Cash from Operations.
- The widest YoY moves for Cash from Operations: up 155.34% in 2025, down 28.21% in 2025.
- Over 4 years, Cash from Operations stood at 11783000.0 in 2023, then advanced by 4.2% to 11288000.0 in 2024, then soared by 155.34% to 6247000.0 in 2025, then tumbled by 275.78% to 10981000.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 10981000.0, 6247000.0, and 11171000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -387.32 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 462.82 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 728.46 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 326.72 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -88.83 Mn |
| 10 | Camp4 Therapeutics | 282.48 Mn | 282.48 Mn | - | -12.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -12.70 Mn |
| Jun 30, 2026 | -12.70 Mn |
| Mar 31, 2026 | -10.98 Mn |
| Mar 31, 2026 | -10.98 Mn |
| Dec 31, 2025 | 6.25 Mn |
| Dec 31, 2025 | 6.25 Mn |
| Sep 30, 2025 | -11.17 Mn |
| Sep 30, 2025 | -11.17 Mn |
| Jun 30, 2025 | -10.34 Mn |
| Jun 30, 2025 | -10.34 Mn |
| Mar 31, 2025 | -14.29 Mn |
| Mar 31, 2025 | -14.29 Mn |
| Dec 31, 2024 | -11.29 Mn |
| Dec 31, 2024 | -11.29 Mn |
| Sep 30, 2024 | -9.69 Mn |
| Sep 30, 2024 | -9.69 Mn |
| Jun 30, 2024 | -13.44 Mn |
| Jun 30, 2024 | -13.44 Mn |
| Mar 31, 2024 | -11.14 Mn |
| Mar 31, 2024 | -11.14 Mn |